Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transmembrane protein 160 pseudogene (ENSG00000267592) is a non-functional genomic region in humans that shares sequence similarity with the functional TMEM160 gene, which encodes an integral mitochondrial membrane protein[2][3][6][9]. Pseudogenes like this arise by gene duplication or retrotransposition and accumulate disabling mutations[2][8], such as early stop codons or frame shifts, preventing them from producing functional proteins[5][8]. Thus, the transmembrane protein 160 pseudogene does **not** encode an active protein, is not classified as a receptor, enzyme, or transporter, and does not serve as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 160 pseudogene.